RxDoctor Payments Data

Scott Reed, MD

Surgical Critical Care · Newport News, VANPI 1528028719

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $96 and has fallen 73.0% since, to $26 in 2025. That places this record below the midpoint for surgical critical care clinicians in VA, where the typical reported total is $2,801.

$243in general payments, 2019–2025

Across 11 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$58
  • Mentor Worldwide LLC$41
  • Intuitive Surgical$36
  • Kerecis Limited$27
  • Humacyte Global, Inc.$26
  • Portola Pharmaceuticals, LLC$24
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$243100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$243 in reported general payments places this provider in the 15th percentile of 60 surgical critical care providers in Virginia.

See all surgical critical care providers in Virginia

Medicare billing

Part B allowed, 2024
$47,435
Medicare patients
169
Services billed
357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl29$59

Paid to pharmacies, not to this prescriber.

Other surgical critical care in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →